bioAffinity Technologies

Business Services · Texas, United States · 51-200 Employees

View Company Info for Free

Overview

Headquarters

3300 Nacogdoches Rd Ste 216, San Antonio...

Phone Number

(210) 698-5334

Revenue

$6.2 Million

Stock Symbol

BIAF

Industry

Business Services Research & Development
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1

About bioAffinity Technologies

bioAffinity Technologies, Inc. engages in developing non-invasive diagnostics to detect early-stage lung cancer and other diseases of the lung. It offers CyPath lung, a diagnostic test, for early detection of lung cancer. The company was incorporated in 2014 and is based in San Antonio, Texas.Explore more
bioAffinity Technologies's Social MediaPopular SearchesBioAffinity Technologies IncbioAffinity TechnologiesBioaffinity IncBioAffinityBioaffinity Farms LLCSIC Code 87,873NAICS Code 54,541Ticker NASDAQ: BIAFShow more

bioAffinity Technologies Org Chart

Maria Zannes, President & Chief Executive Officer at bioAffinity Technologies
United States flag for contact location.

President & Chief Executive Officer

Flame icon indicating likelihood to engage via phone.PhoneFlame icon indicating likelihood to engage via email.Email
J. Michael Edwards, Chief Financial Officer at bioAffinity Technologies
United States flag for contact location.

Chief Financial Officer

PhoneEmail
Xavier Reveles, Chief Operating Officer at bioAffinity Technologies
United States flag for contact location.

Chief Operating Officer

PhoneEmail
TZ
United States flag for contact location.

Executive VP & General Counsel & Secretary

PhoneEmail
Gordon Downie, Chief Medical Officer at bioAffinity Technologies
United States flag for contact location.

Chief Medical Officer

PhoneEmail
DC
United States flag for contact location.

Vice President, Sales

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.
LC
United States flag for contact location.

Director, Accounting

Flame icon indicating likelihood to engage via phone.PhoneFlame icon indicating likelihood to engage via email.Email

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is bioAffinity Technologies your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to bioAffinity Technologies

Compare insights from companies similar to bioAffinity Technologies, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

bioAffinity Technologies

$6.2M
51-200
Public
$13.3M
2014
Maria Zannes, President & Chief Executive Officer at bioAffinity Technologies
Maria ZannesPresident & CEO
$28.6M
11-50
Private
$53M
2011
SB
Sunanda BhargavaVice President, Product Development
$15.3M
51-200
Private
$9.5M
2013
Joost de Schutter, Chief Financial Officer, Fractional at CellMax Life
Joost de SchutterChief Financial Officer, Fractional
$8.9M
11-50
Private
$21.9M
2003
JD
James DiGuiseppiChief Technology Officer
$7.3M
51-200
Private
-
2000
MS
Marla SteuerDirector, Supplier Relations
$5.3M
51-200
Private
$20M
2016
Jeremiah Au, Chief Operating Officer at Lucence
Jeremiah AuChief Operating Officer
<$5M
11-50
Private
-
-
Michelle Pek, Chief Technology Officer at Lucence
Michelle PekChief Technology Officer
Illustration of an envelope

Company Profile Activity

i

Among all Business Services companies

Low Activity

High Activity

Activity Insights

bioAffinity Technologies is experiencing very low activity levels compared to other companies in the Business Services sector.

What does this means?

bioAffinity Technologies is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about bioAffinity Technologies.

bioAffinity Technologies financials insights

Gather financial insights about bioAffinity Technologies, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.

2017

Series A

$4M

2020

Debt

$150K

Debt

$5M

2021

Debt

$212K

2024

Share Placement

$2.5M

2025

Share Placement

$1.4M

See All bioAffinity Technologies's Financials Insights

bioAffinity Technologies Tech Stack

A closer look at the technologies used by bioAffinity Technologies

Most Recent Scoops

Project
Laboratory Operations, Medical Research, Clinical Operations
Executive Move
Executive Moves, Board of Directors
New Hire
Executive Move
Executive Moves, New Hire
Funding
Funding
Project
Intellectual Property, Legal Affairs, Pharmaceuticals, Healthcare Technology
See more scoops

bioAffinity Technologies News & Media

Read more news

Top Business Services Companies

Frequently Asked Questions Regarding bioAffinity Technologies

What is bioAffinity Technologies's stock symbol?
bioAffinity Technologies's stock symbol is BIAF
What is bioAffinity Technologies's official website?
bioAffinity Technologies's official website is www.bioaffinitytech.com
What is bioAffinity Technologies's Revenue?
bioAffinity Technologies's revenue is $6.2 Million
What is bioAffinity Technologies's SIC code?
bioAffinity Technologies's SIC: 87,873
What is bioAffinity Technologies's NAICS code?
bioAffinity Technologies's NAICS: 54,541
How many employees does bioAffinity Technologies have?
bioAffinity Technologies has 51-200 employees
What industry does bioAffinity Technologies belong to?
bioAffinity Technologies is in the industry of: Business Services, Research & Development
What is bioAffinity Technologies competition?
bioAffinity Technologies top competitors include: Lucence, DiaCarta, CellMax Life, Lucence
What technology does bioAffinity Technologies use?
Some of the popular technologies that bioAffinity Technologies uses are: WooCommerce, WordPress.org, reCAPTCHA, PHP
Who is the CFO of bioAffinity Technologies?
bioAffinity Technologies's CFO is J. Michael Edwards
How do I contact bioAffinity Technologies?
bioAffinity Technologies contact info: Phone number: (210) 698-5334 Website: www.bioaffinitytech.com
What does bioAffinity Technologies do?

bioAffinity Technologies, Inc. engages in developing non-invasive diagnostics to detect early-stage lung cancer and other diseases of the lung. It offers CyPath lung, a diagnostic test, for early detection of lung cancer. The company was incorporated in 2014 and is based in San Antonio, Texas.... Read More

What are bioAffinity Technologies social media links?
bioAffinity Technologies Linkedin page bioAffinity Technologies Twitter page bioAffinity Technologies Facebook page
Who invested in bioAffinity Technologies?
bioAffinity Technologies has 6 investors including WallachBeth Capital, PPP, Undisclosed and PPP.
Is bioAffinity Technologies a public company?
Yes, bioAffinity Technologies is a public company and is traded under the symbol BIAF
See more information about bioAffinity Technologies

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.